{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:29:04Z","timestamp":1790612944625,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["201486\/Z\/16\/Z"],"award-info":[{"award-number":["201486\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["80354"],"award-info":[{"award-number":["80354"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["095844\/Z\/11\/Z"],"award-info":[{"award-number":["095844\/Z\/11\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["088869\/Z\/09\/Z"],"award-info":[{"award-number":["088869\/Z\/09\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","award":["RP-PG-0606-1335"],"award-info":[{"award-number":["RP-PG-0606-1335"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["124257"],"award-info":[{"award-number":["124257"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["212828"],"award-info":[{"award-number":["212828"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["214273"],"award-info":[{"award-number":["214273"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004325","name":"Signe and Ane Gyllenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["268336"],"award-info":[{"award-number":["268336"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K006665\/1"],"award-info":[{"award-number":["MR\/K006665\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Applied Health Research & Care"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbi.2016.09.008","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T23:09:29Z","timestamp":1473721769000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study"],"prefix":"10.1016","volume":"59","author":[{"given":"Stephen A.","family":"Metcalf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Nordstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Timonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirjo","family":"M\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Miettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjo-Riitta","family":"J\u00e4rvelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stochl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham K.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golam M.","family":"Khandaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2016.09.008_b0005","first-page":"443","article-title":"Herpes simplex virus antibodies in the cerebrospinal fluid of schizophrenic patients","volume":"31","author":"Bartova","year":"1987","journal-title":"Acta Virol."},{"key":"10.1016\/j.bbi.2016.09.008_b0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0020","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia","volume":"61","author":"Brown","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0030","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.58.11.1032","article-title":"Maternal infections and subsequent psychosis among offspring","volume":"58","author":"Buka","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/brbi.2001.0644","article-title":"Maternal cytokine levels during pregnancy and adult psychosis","volume":"15","author":"Buka","year":"2001","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0040","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1176\/appi.ajp.2014.13121579","article-title":"Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort","volume":"171","author":"Canetta","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbi.2016.09.008_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.2007.07050740","article-title":"Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects","volume":"165","author":"Dalman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0055","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2016.09.008_b0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1017\/S0033291700011764","article-title":"Herpes simplex virus, cytomegalovirus and Epstein\u2013Barr virus antibody titres in sera from schizophrenic patients","volume":"16","author":"Delisi","year":"1986","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2016.09.008_b0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0070","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bbi.2008.04.156","article-title":"Association between cognitive functioning, exposure to herpes simplex virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder","volume":"22","author":"Dickerson","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2011.10.003","article-title":"Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia","volume":"134","author":"Dickerson","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2016.09.008_b0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(94)90042-6","article-title":"Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness","volume":"51","author":"Ganguli","year":"1994","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2016.09.008_b0090","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1038\/tp.2013.5","article-title":"Neonatal levels of acute phase proteins and later risk of non-affective psychosis","volume":"3","author":"Gardner","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0100","series-title":"Schizophrenia: The Epigenetic Puzzle","author":"Gottesman","year":"1982"},{"key":"10.1016\/j.bbi.2016.09.008_b0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/00365510410002931","article-title":"Highly sensitive determination of C-reactive protein on the Innotrac Aio! immunoanalyzer","volume":"64","author":"Hedberg","year":"2004","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bbi.2016.09.008_b0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1176\/appi.ajp.2012.11081197","article-title":"Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring","volume":"169","author":"Karlsson","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0115","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00213-015-3975-1","article-title":"Is there a role for immune-to-brain communication in schizophrenia?","volume":"233","author":"Khandaker","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2016.09.008_b0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2012.05.023","article-title":"Childhood infection and adult schizophrenia: a meta-analysis of population-based studies","volume":"139","author":"Khandaker","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2016.09.008_b0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1017\/S0033291712000736","article-title":"Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies","volume":"43","author":"Khandaker","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2016.09.008_b0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2013.09.021","article-title":"A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence","volume":"152","author":"Khandaker","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2016.09.008_b0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.annepidem.2014.11.013","article-title":"A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis","volume":"25","author":"Khandaker","year":"2015","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.bbi.2016.09.008_b0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","article-title":"Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine","volume":"89","author":"Maes","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2016.09.008_b0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","article-title":"Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice","volume":"22","author":"Meyer","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0170","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0175","first-page":"1","article-title":"C-reactive protein levels in schizophrenia","author":"Miller","year":"2013","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.bbi.2016.09.008_b0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2016.09.008_b0185","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/schbul\/sbm009","article-title":"Early infections of Toxoplasma gondii and the later development of schizophrenia","volume":"33","author":"Mortensen","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2016.09.008_b0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"Muller","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0195","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbi.2011.05.005","article-title":"Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients","volume":"25","author":"Myint","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbi.2016.09.008_b0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2012.02.019","article-title":"Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study","volume":"138","author":"Pedersen","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2016.09.008_b0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Perala","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/08039480801983596","article-title":"The validity of schizophrenia diagnosis in the Finnish Hospital Discharge Register: findings from a 10-year birth cohort sample","volume":"62","author":"Pihlajamaa","year":"2008","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0220","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0230","doi-asserted-by":"crossref","first-page":"605810","DOI":"10.1155\/2014\/605810","article-title":"C-reactive protein: clinical and epidemiological perspectives","volume":"2014","author":"Salazar","year":"2014","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.bbi.2016.09.008_b0235","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbi.2008.07.012","article-title":"Activation of the maternal immune system alters cerebellar development in the offspring","volume":"23","author":"Shi","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2016.09.008_b0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2016.09.008_b0250","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish Hospital Discharge Register: a systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.bbi.2016.09.008_b0255","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2016.09.008_b0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2016.09.008_b0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2015.03.009","article-title":"Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation","volume":"48","author":"Weir","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2016.09.008_b0270","series-title":"The ICD-10 Classification of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines","author":"WHO","year":"1992"},{"key":"10.1016\/j.bbi.2016.09.008_b0275","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/schbul\/sbt120","article-title":"Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study","volume":"40","author":"Wium-Andersen","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2016.09.008_b0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.CIR.0000053731.05365.5A","article-title":"Coming of age of C-reactive protein: using inflammation markers in cardiology","volume":"107","author":"Yeh","year":"2003","journal-title":"Circulation"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116304172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159116304172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T21:25:36Z","timestamp":1740432336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159116304172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":56,"alternative-id":["S0889159116304172"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2016.09.008","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2016.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}